Trials / Completed
CompletedNCT00865176
Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting Conditions
Comparative Bioavailability Study of Eplerenone 50 mg Tablets (Sandoz Inc., USA) and Inspra 50 mg Tablets (GD Searle LLC, USA) in Healthy Male and/or Female Volunteers Under Fasting Conditions.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to demonstrate the relative bioequivalence of Eplerenone 50 mg ER Tablets under fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Eplerenone 50 mg Tablets Sandoz Inc., USA | |
| DRUG | Inspra 50 mg Tablets GD Searle LLC, USA |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2006-07-01
- Completion
- 2006-07-01
- First posted
- 2009-03-19
- Last updated
- 2017-03-29
Source: ClinicalTrials.gov record NCT00865176. Inclusion in this directory is not an endorsement.